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First Epidemic of Echovirus 16
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Cuba and †Ministry of Public Health, Havana, Cuba
From April to September 2000, an epidemic of aseptic meningitis spread
throughout Cuba, with 16,943 reported cases. Virologic studies identified
echovirus 16 as the cause of this epidemic. This is the first reported isolate
of echovirus 16 from patients with viral meningitis in Cuba.
The Study
From April 30 to September 2000, Cuban health author-
ities reported a marked increase in acute aseptic meningitis
cases. The peak incidence occurred in July (49.6 cases per
100,000 population) (Figure 1). The index cases appeared in
Cienfuegos Province, in the central part of the country. Sub-
sequently, the disease was widely distributed: 16,943 cases
were reported from April to September 2000.
Most patients were children <15 years old. The age-spe-
cific peak incidence occurred in infants <1 year of age, but
none were neonates (Figure 2). Vomiting (91.5%), headache
(88.1%), and fever (72.8%) were the predominant clinical
manifestations; few patients had diarrhea (11.8%) or skin
rash (6.8%). Cerebrospinal fluid (CSF) cell counts showed
>100 leukocytes/mm3 in 40% of patients. The rest of the CSF
counts were 10-100 leukocytes/mm3. No deaths related to
aseptic meningitis were reported, and all patients recovered
completely. 
To establish the outbreak-associated enterovirus, 54
CSF, 76 fecal samples, and 31 paired sera from acute and
convalescent phases were obtained from 98 children with
symptoms suggestive of aseptic meningitis. CSF and fecal
samples were collected only once per child, at onset of symp-
toms. The children were admitted into hospitals in 11 of
Cuba’s 14 provinces. Specimens were collected from May 5 to
August 11, 2000, and transported frozen to our laboratory.
We used conventional methods for diagnosis of enterovi-
rus and an in-house-developed reverse transcriptase-nested
polymerase chain reaction (RT-N-PCR) assay of CSF speci-
mens. For the enterovirus genome detection, RNA was
extracted from 250 µL of CSF using TRIzol (Life Technolo-
gies TM, GIBCO BRL; Grand Island, NY), according to the
manufacturer’s instructions. RNA amplification was per-
formed by the method of Kilpatrick et al. (1), except that two
amplification rounds were used.  Oligonucleotides were
derived from the 5'noncoding region (5'NCR), a highly con-
served zone in enterovirus serotypes that allows a near-uni-
versal amplification of the enteroviruses (2,3). 
Specificity of the RT-N-PCR assay was confirmed by
detection of amplification products of RNA extracted from
cell culture fluids infected with polioviruses sabin 1-3, cox-
sackievirus A9 and A16, and the most common epidemic
types of echoviruses (echovirus 4,6,9,11,30), as well as by the
absence of amplified cDNA with RNA extracted from herpes-
virus family-infected and noninfected monkey kidney cells
(Vero). The recognized sensitivity (0.01 50% tissue culture
infective dose) and specificity of our enterovirus-RNA detec-
tion assay allowed us to detect specific enterovirus RNA
sequences in 46.3% (25 of 54) of CSF specimens. We do not
believe that positive results were due to PCR contamination
because universal precautions were adopted (4). An equal
number of test samples and reagent controls were processed
in each test batch to prevent contamination of RNA extrac-
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tion by extraneous nucleic acid sequences; PCR reagents
were amplified by PCR. The reagent controls’ reaction veri-
fied the absence of contamination at all stages of the PCR
process. 
The application of this in-house RT-N-PCR assay guar-
anteed the rapid etiologic diagnosis of this epidemic. How-
ever, our RT-N-PCR is unable to determine the enterovirus
serotype, which is necessary to understand the epidemiology
of enterovirus infections.
For enterovirus isolation, 200 µL of CSF and fecal speci-
mens were inoculated in duplicate into tubes covered with
monolayers of fibroblastic diploid embryonic human cells
(PhuE-1) and Vero cells. From the 76 fecal specimens inocu-
lated, 45 (59.2%) induced cytopathic effect (CPE). This CPE
was only evident in the PhuE-1 cell monolayers; Vero cells
remained unchanged. Viral isolation was possible from all
the tubes showing CPE. However, no enterovirus strains
were recovered by cell culture isolation from any CSF speci-
men. These discrepancies could be explained by the massive
excretion of viral particles in feces. Moreover, previous stud-
ies have demonstrated that enteroviruses are isolated from
CSF in only a few cases with acute aseptic meningitis
because viral particles are present in low titers in CSF (5-7).
Nevertheless, a higher positivity was obtained from 20 CSF
samples when RT-N-PCR was used than for 20 samples of
feces from the same patients when evaluated by viral isola-
tion. Only 10 of the 16 CSF specimens positive by PCR could
be correlated with a positive fecal culture, whereas the 4
PCR-negative CSF samples correlated well with the absence
of viral isolation from the related fecal specimens. 
CPEs produced by isolated strains were typical of those
characterizing enteroviruses (e.g., cell rounding followed by
shrinkage and degeneration of the cell sheet). However, at
the beginning of the epidemic, isolated strains produced a
CPE that progressed slower (slow-CPE) than typical
enterovirus isolates do. The inoculated cultures had to be
subpassaged weekly at least 5 times to obtain the typical
degenerative CPE of enterovirus. By the late stages of the
epidemic, CPE produced by isolated strains became evident
at the first passage (fast-CPE). No slow-CPE isolates were
detected late in the epidemic, and there was no evidence of
“fast CPE-to-slow CPE” reversion of isolates late in the epi-
demic. Nevertheless, no changes in the clinical outcome of
the infection were observed during the epidemic. It is tempt-
ing to speculate that the genetic constitution of the selected
viral population could be substantially different from that of
the original strain. This phenomenon could explain the vari-
ation in CPE during the epidemic.
All strains from the epidemic were identified as echovi-
rus 16 by a neutralization test using Lim-Benyesh-Melnick
antisera pools. To corroborate the infecting serotype, pres-
ence of a fourfold or greater increase of type-specific virus-
neutralizing antibody titers between acute- and convales-
cent-phase serum specimens was determined; 54.8% (17 of
31) of the patients’ sera exhibited a significant rise of neu-
tralizing antibody titer against the isolated strains. The geo-
metric mean titers of the first and second sera were 1:3.4;
and 1:22.4, respectively.
Previous studies in Cuba have estimated the circulation
of enterovirus in patients with meningitis. From 1972 to
1999, seven meningitis outbreaks caused by an enterovirus
occurred: echovirus 4 (1972 and 1985-86), coxsackievirus B5
(1976 and 1995), coxsackievirus A9 (1990-1991), echovirus
30 (1994), and echovirus 9 (1999). Other enteroviruses (cox-
sackievirus and numerous echoviruses) were identified from
sporadic cases of viral meningities during nonepidemic peri-
ods (6). Before this epidemic, aseptic meningitis caused by
echovirus 16 had never been recognized in Cuba. 
Nevertheless, the age distribution in this outbreak sug-
gests previous exposure and immunity to echovirus 16 in
older persons (Figure 2). The age group distribution was also
similar to that in previously described outbreaks of aseptic
meningitis in Cuba (6). A possible explanation for this age
distribution is that an antigenically related virus without
potential to cause acute aseptic meningitis circulated in the
population before year 2000 and induced an immune
response. Alternatively, maternal antibodies against this
virus may protect neonates from infection.
Factors influencing the prevalence of enteroviruses are
poorly understood. The ease with which a type of nonpolio
enterovirus can be isolated, however, is likely to be a major
determinant of the frequency with which it is reported (5,8).
Echovirus 16 isolates associated with sporadic cases of asep-
tic meningitis have probably been infrequently reported in
previous years because of the difficulties in tissue culture
propagation.
According to data collected through the U.S. National
Enterovirus Surveillance System, echovirus 16 is routinely
isolated, but the frequency of its isolation is low in most
years (i.e., 3 to 5 cases per year) (Centers for Disease Control
and Prevention, unpub. data).
To our knowledge, the last Cuban outbreak of aseptic
meningitis associated with echovirus 16 infections occurred
in Tajimi City, Gifu prefecture, in 1984. Diverse etiologic
agents (coxsackievirus B1, B4, and B5) were also reported
during the outbreak (9).
The emergence of echovirus 16 associated with a very
large-scale meningitis epidemic in Cuba should alert public
health officials to the potential for epidemics associated with
this serotype in other areas of the world.
The overall genetic diversity and molecular evolution in
echovirus 16 strains and the correlation with the epidemio-
logic features of echovirus 16-associated disease have not yet
been studied. The availability of the viral isolates, together
with the massive clinical and epidemiologic data from this
epidemic, represents an unprecedented opportunity to study
the emergence of echovirus 16 strains and their subsequent
molecular evolution.
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